CA1262686A - Compose pour soulager les nausees et les vomissements - Google Patents

Compose pour soulager les nausees et les vomissements

Info

Publication number
CA1262686A
CA1262686A CA000481696A CA481696A CA1262686A CA 1262686 A CA1262686 A CA 1262686A CA 000481696 A CA000481696 A CA 000481696A CA 481696 A CA481696 A CA 481696A CA 1262686 A CA1262686 A CA 1262686A
Authority
CA
Canada
Prior art keywords
composition
composition according
pharmaceutically acceptable
metoclopramide
sodium metabisulphite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000481696A
Other languages
English (en)
Inventor
Ian Patrick O'brien
Ram Dutta Pathak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of CA1262686A publication Critical patent/CA1262686A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000481696A 1984-05-17 1985-05-16 Compose pour soulager les nausees et les vomissements Expired CA1262686A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8412585 1984-05-17
GB848412585A GB8412585D0 (en) 1984-05-17 1984-05-17 Composition

Publications (1)

Publication Number Publication Date
CA1262686A true CA1262686A (fr) 1989-11-07

Family

ID=10561084

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000481696A Expired CA1262686A (fr) 1984-05-17 1985-05-16 Compose pour soulager les nausees et les vomissements

Country Status (5)

Country Link
AU (1) AU623694B2 (fr)
CA (1) CA1262686A (fr)
GB (2) GB8412585D0 (fr)
NZ (1) NZ212097A (fr)
ZA (1) ZA853671B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI871447A (fi) * 1986-04-07 1987-10-08 Bristol Myers Co Stabila injicerbara antivomitiva kompositioner.
DE4131276B4 (de) * 1990-09-28 2007-07-19 Solvay Pharmaceuticals Gmbh Peroral applizierbare Metoclopramidlösungen
CH681690A5 (en) * 1990-09-28 1993-05-14 Kali Chemie Pharma Gmbh New metoclopramide salt compsns. with no additives
US5561161A (en) * 1994-03-25 1996-10-01 Oxigene, Inc. Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme

Also Published As

Publication number Publication date
GB2158714B (en) 1989-01-05
AU623694B2 (en) 1992-05-21
GB2158714A (en) 1985-11-20
AU4362489A (en) 1990-03-01
ZA853671B (en) 1986-04-30
NZ212097A (en) 1988-11-29
AU591631B2 (en) 1989-12-14
AU4260785A (en) 1985-11-21
GB8510115D0 (en) 1985-05-30
GB8412585D0 (en) 1984-06-20

Similar Documents

Publication Publication Date Title
Sreter et al. Effect of adrenergic blocking agents on running ability in the rat
JPS62185017A (ja) 変形性関節症および関連した病気の治療のためのｎ−アセチルグルコサミンの使用
US6720011B1 (en) Injectable composition for cancer treatment
CA1262686A (fr) Compose pour soulager les nausees et les vomissements
CA2166704C (fr) Medicaments a l'arsenic pour le traitement du syndrome de fatigue chronique
US5081153A (en) Sterile parenteral composition
EP0609701A1 (fr) L-cysteine, L-cystine, ou L-glutamine comme agent thérapeutique supplémentaire dans le traitement du syndrome d'immunodéficience
US4569929A (en) Cytidyl diphosphocholine-drug composition
IE790194L (en) Pharmaceutical formulation
US4439451A (en) Treatment of the blood-brain barrier with flurbiprofen
EP1166773B1 (fr) Solution de N-[O-(p-pivaloyloxybenzènesulfonylamino)benzoylglycine sel monosodique tétrahydrate et médicament contenant cette solution
US2518510A (en) Stable injectable oil-pectin therapeutic compositions
US4439450A (en) Treatment of the blood-brain barrier with ibuprofen
US5510390A (en) Anti-hypertensive composition and methods of treatment
GB2050164A (en) Ionising radiation protective compositions
US6818662B2 (en) Pharmaceutical composition
US2995491A (en) Method of treating cardiac arrhythmia with 1-(2-diethylaminoethyl)-5-ethyl-5-phenylbarbituric acid
US3885030A (en) Medicine comprising lysine by-products
US3894153A (en) Method of medical treatment of asthma
US6159965A (en) Anti-emetic pharmaceutical compositions containing methotrimeprazine
CA1142855A (fr) Compose anti-tumoral et procede de preparation
CN1141145C (zh) 锝[99Tc]膦酸盐药物在制备治疗甲亢伴浸润性凸眼的药物中的应用
CN105193776B (zh) 一种复方视神经保护和抗青光眼药物组合物
WO1988009665A1 (fr) Pommades ophtalmiques sans conservateurs
IL34670A (en) Pharmaceutical preparations containing 2-) 2,6-dichlorophenyl-amino (-1,3-diazacicopentane-) 2) and / or its acidic salt salts

Legal Events

Date Code Title Description
MKEX Expiry